EGS Health, health-tech companies based in Visakhapatnam has announced the launch of Medicas Comprehensive Cancer Care (MC3), a cancer care coordination platform designed to help patients access expert-led second opinions, multidisciplinary oncology guidance, and coordinated cancer care support across India.
The service focuses on different step of care from early cancer detection to recovery with exceptional patient emotional support during this journey. MC3 is designed to quickly add clarity around treatment options driven by data driven clinical solutions.
Backed by a panel of leading national and international oncologists, MC3 has been launched nationwide to help bridge the growing gap in access to specialised cancer care, particularly for patients in Tier 2 and Tier 3 cities where multidisciplinary oncology expertise and subspecialised guidance may not always be readily available. The platform brings together experienced Indian and global cancer specialists to support patients and their families with collaborative, expert-led treatment guidance tailored to individual clinical needs.
MC3 follows a hands-on, human-led approach where all recommendations are provided by a panel of doctors in consultation with the patient’s primary healthcare provider and the patient. The service is designed to help patients navigate increasingly complex cancer treatment pathways through coordinated support across areas including precision oncology, rehabilitation, psycho-oncology, supportive care, and palliative care guidance.
Speaking on the launch, Shiva Shankar, Chairman and MD, EGS Group of Companies said, “Cancer care today requires timely access to multidisciplinary expertise, coordinated guidance, and compassionate patient support. With MC3, our vision is to help patients across India access world-class oncology expertise regardless of geography, while ensuring every treatment decision remains collaborative, patient-centric, and guided by experienced specialists.”
Dr Hari Parameswaran, CMO, MC3 added, “Cancer treatment is evolving rapidly with advances in precision medicine and targeted therapies, making access to specialised expertise more important than ever. MC3 has been built to support patients and treating physicians through expert-led second opinions and coordinated cancer care guidance that helps patients make more informed and confident decisions throughout their treatment journey.”